Bristol-Myers Squibb Company (NYSE:BMY) - Share price - Overview

Stock Report

Bristol-Myers Squibb Company BMY

Last Price
$63.36

Day Change
0.03|0.05%

As of 22/09/2017
18:54:09 EDT | USD
Minimum 15 Minutes Delay.

Last Close63.33
Day Range63.04 - 63.55
Mkt Cap103.90Bil
52-Wk Range46.01 - 63.74
Yield %2.45
ISINUS1101221083
Volume3,667,202
P/E23.12
P/S5.23
P/CF20.82

Share Price

Financials
201420152016
More ...
Income Statement
Revenue15,879.0016,560.0019,427.00
Operating Income2,591.001,890.004,630.00
Net Income2,004.001,565.004,457.00
Basic EPS1.210.942.67
Avg. Diluted Shares Outstanding1,6701,6791,680
Balance Sheet
Current Assets14,608.0010,415.0013,704.00
Non Current Assets19,141.0021,333.0020,003.00
Total Assets33,749.0031,748.0033,707.00
Current Liabilities8,461.008,017.008,841.00
Total Liabilities18,897.0017,482.0017,530.00
Total Equity14,852.0014,266.0016,177.00
Cash Flow
Operating Cash Flow3,148.001,832.002,850.00
Capital Expenditure-526.00-820.00-1,215.00
Free Cash Flow2,622.001,012.001,635.00

In millions, except "Basic EPS". Currency is USD.

Company Profile

Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and nutritional products. The company operates in two segments namely Pharmaceuticals and Nutritionals.

Sector

Healthcare

Industry

Drug Manufacturers - Major

Stock Style

Large-Blend

Fiscal Year Ends

December

Employees

25,000
Key Stats
More ...
Price/Earning TTM22.86
Price/Book7.07
Price/Sales TTM5.23
Rev Growth (3 year avg)5.84
EPS Growth (3 year avg)-
Operating Margin % TTM23.83
Net Margin % TTM22.94
ROE TTM29.28
Debt/Equity0.35
Dividends
PreviousLatest
More ...
Declared Date13/06/1714/09/17
Ex-Div05/07/1705/10/17
Paid01/08/1701/11/17
Amnt0.390.39
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.